Avalanche Biotechnologies (AAVL) Plummets on Q2 Loss

Avalanche Biotechnologies Inc

shares dropped 28.2% to $9.93. Avalanche reported a Q2 loss of $0.38 per share on revenue of $279,000 and issued an update on AVA-101 program. Share volume was 774,000, compared to an all-day average of 201,000